A股異動丨華峯化學(002064.SZ)漲逾4% 300000噸/年差別化氨綸項目取得積極進展
格隆匯9月28日丨華峯化學(002064.SZ)漲逾4%,報12.8元,總市值593億元。

華峯化學昨日公吿稱,此前披露公司控股子公司華峯重慶氨綸有限公司投資建設300000噸/年差別化氨綸項目。2021年8月,重慶氨綸與重慶涪陵公共資源交易有限公司簽訂了《國有建設用地使用權出讓成交確認書》,取得了由重慶市涪陵區規劃和自然資源局頒發的《中華人民共和國不動產權證書》。
該項目將採用新設備、新工藝、新技術,建成後公司的生產規模將進一步擴大,整體生產成本將進一步降低,市場佔有率和影響力將顯著提升,為公司帶來較為豐厚的利潤回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.